(S)-1-(4-Fluorophenyl)ethanamine hydrochloride, 97.0%, 1g

2,6-Difluoro-3-iodophenol, 98%, 500mg

5-Fluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]indazole-3-carboxylic acid, 97%, 250mg

6-BROMO-7-METHOXYQUINOLIN-4-OL, 95.0%, 250mg

4-(2-Amino-thiazol-4-yl)-benzoic acid, 95.0%, 5g

3-Bromo-2,5-difluorobenzaldehyde, 95.0%, 10g

tert-Butyl 3-hydroxycyclobutane-1-carboxylate, 98%, 500mg

GC capillary column ROTI®Cap-5 HT, 15 m, 0.25 mm, 0.10 µm, 1 Piece(s)

6,6-Difluoro-3-azabicyclo[3.1.0]hexane oxalate(2:1), 95.0%, 5g

4-Amino-3,5-dimethoxybenzoic acid, 95.0%, 5g

3-Chloro-2,4,5,6-tetrafluoropyridine, 99.0%, 100g

Triethoxy(propyl)silane>98.0%(GC)25g

tert-Butyl 4-(2-methoxy-2-oxoethyl)piperidine-1-carboxylate, 95.0%, 1g